Navigation Links
Meditrina Pharmaceuticals, Inc. Opens Investigational New Drug (IND) Application for Phase IIb Clinical Trial With MPI-676 in Endometriosis
Date:7/17/2008

ting the enzyme aromatase, which is responsible for converting certain hormones to estrogen. In endometriosis, AIs act primarily by inhibiting local estradiol production inside the endometrial lesions. AIs are currently used for the chronic treatment of estrogen-dependent tumors in postmenopausal women and are being investigated in a variety of women's health conditions. Meditrina holds the exclusive worldwide rights to patent applications covering the use of AIs in gynecologic indications, including for endometrial thinning prior to hysteroscopic procedures.

About Meditrina Pharmaceuticals, Inc.

Meditrina Pharmaceuticals, Inc. is a clinical-stage, specialty pharmaceutical company focused on developing and commercializing innovative therapies that treat women's reproductive system disorders, with an initial focus on gynecologic and aromatase-mediated conditions with serious unmet medical needs. By identifying, leveraging and repurposing marketed products and product candidates at advanced stages of development, Meditrina's novel therapies have the potential to significantly alter the way these women's health conditions are treated. For more information about Meditrina Pharmaceuticals, please visit http://www.meditrina.com .

Meditrina Pharmaceuticals, Inc. Forward-Looking Statement Disclaimer

This announcement may contain, in addition to historical information, certain forward-looking statements that involve risks and uncertainties. Such statements reflect management's current views and are based on certain assumptions. Actual results could differ materially from those currently anticipated as a result of a number of factors. The company is developing several products for potential future marketing. There can be no assurance that such development efforts will succeed, that such products will receive required regulatory clearance or that, even if such regulatory clearance were received, s
'/>"/>

SOURCE Meditrina Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Keryx Biopharmaceuticals, Inc. Announces Phase 2 Results on KRX-0401 (Perifosine) in Patients with Relapsed/Refractory Waldenstroms Macroglobulinemia at the 44th Annual Meeting of the American Society of Clinical Oncology
2. Auxilium Pharmaceuticals, Inc. Announces XIAFLEX(TM) Meets Primary Endpoint With Statistical Significance (p<0.001) in CORD I Pivotal Phase III Study for Dupuytrens Contracture
3. Keryx Biopharmaceuticals, Inc. Announces Poster Presentation Highlighting Observed Clinical Activity of KRX-0401 (Perifosine) at the American Society of Clinical Oncology Meeting in Chicago, Illinois
4. Jazz Pharmaceuticals, Inc. Completes Enrollment in First of Two Phase III Clinical Trials of Sodium Oxybate to Treat Fibromyalgia
5. Arena Pharmaceuticals, Inc. Announces Initiation of Phase 1 Clinical Trial of Drug Candidate Under Partnership with Taisho Pharmaceutical Co., Ltd.
6. Alseres Pharmaceuticals, Inc. to Address a Congressional Briefing on Paralysis Research and the Spinal Cord Injury Community at Working 2 Walk in Washington, DC, April 13-15, 2008
7. Lotus Pharmaceuticals, Inc. Achieves Significant Milestones in the Development of Isosorbide Mononitrate Sustained Release Tablets
8. Jazz Pharmaceuticals, Inc. Announces Receipt of FDA Orphan Drug Designation for Recurrent Acute Repetitive Seizures Product Candidate
9. Solvay Pharmaceuticals, Inc. Responds to Advisory Committee Recommendation for Further Study of Tedisamil to Treat Atrial Fibrillation
10. Keryx Biopharmaceuticals, Inc. Announces Phase 1 and Phase 2 Data on KRX-0401 (Perifosine) in Patients with Relapsed/Refractory Multiple Myeloma at 49th Annual Meeting of American Society of Hematology
11. Quark Pharmaceuticals, Inc. Announces First Systemic siRNA Dosing in Humans
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/4/2015)... , March 4, 2015 Following the ... Legal Action Center (LAC) released a report today ... growing opioid and heroin epidemic through more effective ... The report, "The Case for Expanding Access to ... Epidemic," outlines the health, justice, and economic advantages ...
(Date:3/4/2015)... 2015  Kannalife Sciences, Inc. ("Kannalife") announces that Dr. ... Advisory Board to assist the Company in the advancement ... of cannabinoid therapeutics for the treatment of Chronic Traumatic ... for conducting the full autopsy of Mike Webster ... the Pittsburgh Steelers. It was through his examination of ...
(Date:3/4/2015)... , March 4, 2015  Students from Indiana ... at how new medicines are discovered. Through a partnership ... fourth-year medical students from IU School of Medicine are ... working at Lilly play different and important roles in ... "As a former medical educator, scientific investigator, and health ...
Breaking Medicine Technology:Improved Medication-Assisted Treatment Policy Could Aid Epidemic of 20 Million Americans with Untreated Addiction 2Kannalife Sciences, Inc. Announces the Addition of Dr. Bennet Omalu, Renowned Pathologist and Founder of Chronic Traumatic Encephalopathy, to its Scientific Advisory Board 2Kannalife Sciences, Inc. Announces the Addition of Dr. Bennet Omalu, Renowned Pathologist and Founder of Chronic Traumatic Encephalopathy, to its Scientific Advisory Board 3Lilly and IU School of Medicine Partner on Rotation Program for Medical Students 2Lilly and IU School of Medicine Partner on Rotation Program for Medical Students 3
(Date:3/4/2015)... Estates, CA (PRWEB) March 04, 2015 ... clever dialogue and lyrical music, will be performed by ... Rolling Hills Estates, CA, this March 6-22, 2015, on ... Arts Center at Peninsula High School (27118 Silver ... available one hour before the program or may be ...
(Date:3/4/2015)... 2015 Columbus is no stranger to drug ... cocaine addiction, and suffers from the potential threat of ... 27th, the DEA revealed that Kratom is a “drug of ... the newly introduced herb from Southeast Asia acts as a ... WKYC notes kratom foments symptoms similar to heroin withdrawal, and ...
(Date:3/4/2015)... (PRWEB) March 04, 2015 The ... discussion leaders for its upcoming fifth annual Advanced ... Paris, France. The event this year will feature ... than 20 of the field’s leading companies and ... together top executives and clinical researchers from the ...
(Date:3/4/2015)... 04, 2015 Today Visiopharm announces that ... has joined the Visiopharm Board of Directors ... time when we are positioned to become the fastest ... cancer diagnostics and research. , "Over the ... development and validation of ONCOtopix™ Dx, a complete quantitative ...
(Date:3/4/2015)... San Jose, California (PRWEB) March 04, 2015 ... global CNS therapeutics market is driven by the increasing ... and an encouraging pipeline of late stage drugs. The ... brings to fore the untapped potential in the market. ... and effective drugs that overcome the limitations of current ...
Breaking Medicine News(10 mins):Health News:The New Mel Brooks Musical Young Frankenstein Performance March 6-March 22, 2015, by the Award Winning Drama Department at Peninsula High School, Rolling Hills 2Health News:Columbus, OH Combats the Sale of Kratom as a Drug, Harbor Village Detox Stresses Caution 2Health News:The Alliance for Regenerative Medicine Announces Agenda for Upcoming Advanced Therapies Summit 2Health News:The Alliance for Regenerative Medicine Announces Agenda for Upcoming Advanced Therapies Summit 3Health News:Visiopharm Appoints Patrik Dahlen as Chairman of the Board 2Health News:Visiopharm Appoints Patrik Dahlen as Chairman of the Board 3Health News:Rising Incidence of CNS Disorders & a Promising Global Drug Pipeline Drive the CNS Therapeutics Market, According to a New Report by Global Industry Analysts, Inc. 2Health News:Rising Incidence of CNS Disorders & a Promising Global Drug Pipeline Drive the CNS Therapeutics Market, According to a New Report by Global Industry Analysts, Inc. 3Health News:Rising Incidence of CNS Disorders & a Promising Global Drug Pipeline Drive the CNS Therapeutics Market, According to a New Report by Global Industry Analysts, Inc. 4
... in Italy have developed a potential new pain-killing drug//. The ... at a public lecture on 20th March. ,Professor ... drug in collaboration with Dr Girolamo Calo in Ferrara Italy, ... of the side effects of morphine, currently the ‘gold standard’ ...
... Zealand: The supply of tetanus vaccine meant for children below seven ... a tizzy to manage replacements.// ,The Pharmaceutical Company CSL ... making the replenishment of stocks impossible. The present stock is just ... ,This scenario would mean that a combination of drugs will ...
... involving more than 65, 000 persons show a positive ... developing cancer//. , Dr. Par Stattin of Umea University Medical ... 33,293 women, led the research. The subjects had ... measurements available. In total 2,478 cases of cancer were identified in ...
... that a child’s race may be a factor ... with environmental tobacco smoke (ETS). //The study reveals ... exposed to ETS, have significantly higher toxin levels ... ,“African American children suffer from higher rates of ...
... body mass index (BMI) tend are less likely to be ... according to a report. ,An ischemic stroke occurs ... brain is blocked or reduced and sufficient amounts of oxygen ... are risk factors for stroke and may influence outcome or ...
... of bloodshot eyes anymore. After sleepless nights, a person’s ability ... been found//. ,Sleep deprivation lowers metabolic activity ... at Walter Reed Army Institute of Research, report in the ... of volunteers to two sleepless nights, they found that participants ...
Cached Medicine News:Health News:Beware of High Sugar Levels Even If You are Not Diabetic 2Health News:Race Affects Tobacco Absorption in Children 2Health News:Stroke Patients With High BMI Less Likely to Be Discharged After Hospitalization 2
Microsurgical straight forceps made of titanium has straight shafts with smooth working surface. TCI working parts 6 mm from tips with round handle, diam. 6 mm, overall length 116 mm....
Curved tying forceps made of titanium has curved shafts with 6 mm V-grove tying platforms, width of shafts 0,5 mm, TCI platforms, flat handle, width 10 mm, overall length 103 mm....
Curved tying spring forceps made of titanium, delicate smooth jaws, length 10 mm, TCI jaws with round handle, diam. 8 mm and overall length 115 mm....
Thornton titanium curved suture tying forceps, 4"....
Medicine Products: